CENTESSA PHARMACEUTICALS-ADR (CNTA)

US1523091007 - ADR

8.97  -0.58 (-6.07%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
6.85M0.000.000.000.00
Operating Expenses
178.14M212.26M153.63M10.44M5.06M
Research and Development
124.41M155.08M95.66M9.30M4.26M
Selling, General, and Administrative Expenses
53.73M55.20M42.89M1.14M790.00K
Operating Income
-171.28M-212.26M-153.63M-10.44M-5.06M
Interest Income/Expense
570.00K-7.03M-1.17M-250.00K10.00K
Other Income/Expense
-5.43M2.34M-5.70M-310.00K-120.00K
Non Recurring Items
N/A0.00-220.45M340.00K110.00K
Income Before Taxes
-176.14M-216.95M-380.96M-10.66M-5.06M
Income Tax
-25.06M-750.00K110.00KN/AN/A
Net Income
-151.09M-216.21M-381.07M-10.66M-5.06M
EBITDA
-170.47M-212.13M-153.60MN/A-5.05M
 
Per Share Data
EPS Diluted Total Ops
-1.38-2.04-4.47-0.11-0.05
Non GAAP EPS
-1.57-2.31N/AN/AN/A
 
Statistics
Profit Margin
-2204.65%N/AN/AN/AN/A
Operating Profit Margin
-2499.39%N/AN/AN/AN/A

All data in USD

Charts